Japan Sees Pharma Research as its Sunrise Sector, Alters Policy to Rev up R&D
This article was originally published in PharmAsia News
Executive Summary
TOKYO - The Japanese Ministry of Health, Labor and Welfare will seek budgetary appropriations or allocations for 2009 to extend research funds to companiesfor developing break-though pharmaceutical products as a national project, according to a MHLW official Aug. 5
You may also be interested in...
PharmAsia News Notable Notes: Japan’s Rising Health Care Funding Gap
Japanese policy makers should reconsider the country's National Health Insurance plan, which focuses on constraining costs rather than the scope of treatment, if they are to avoid a funding gap created by rising health care costs, according to a report by the economic research and consulting firm McKinsey Global Institute
Japan To Cut Drug Prices in April
TOKYO - In the beginning of March, Japan's Ministry of Health, Labour and Welfare plans to release a full list of drugs that will be repriced starting in April. The average price cut is expected to be roughly 5.2 percent and includes top-selling prescription drugs